SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-18-010802
Filing Date
2018-08-01
Accepted
2018-08-01 16:30:40
Documents
7
Period of Report
2018-07-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 41676
2 ex4-1.htm EX-4.1 119704
3 ex5-1.htm EX-5.1 11387
4 ex10-1.htm EX-10.1 236109
5 ex10-2.htm EX-10.2 78714
6 ex99-1.htm EX-99.1 14284
7 ex99-1_001.jpg GRAPHIC 8214
  Complete submission text file 0001493152-18-010802.txt   514475
Mailing Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501
Business Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501 510-775-0515
OncoCyte Corp (Filer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37648 | Film No.: 18985189
SIC: 2835 In Vitro & In Vivo Diagnostic Substances